Nincic D, Mandic A, Dugandzija T, Zivaljevic M, Rajovic J, Vojinovic D
Department of Gynecologic Oncology, Institute of Oncology Vojvodina, Sremska Kamenica, Serbia.
J BUON. 2009 Oct-Dec;14(4):669-72.
Cervical cancer is the leading cause of death in women with gynecological cancers in Vojvodina. Serbia currently holds the leading place in Europe regarding the incidence of cervical carcinoma and comes second in terms of mortality.
Data were retrieved from the Register for malignant neoplasms of the Institute of Oncology Vojvodina for the period 2001-2007. The patients were divided in 3 groups according to the stage of disease based on the FIGO classification for cervical cancer. Data were analysed using linear trend and t-test.
The linear trend of the number of registered cases in the group of stage I-IIA patients during 7 years showed no significant change in the prevalence of the disease. In the group of women diagnosed with stage IIB no statistical difference regarding either a rising or a decreasing trend was observed. The observed trend in an advanced disease stage (III and IV) showed a slight decrease in the number of patients, but without statistical significance.
The linear trend of the number of patients with cervical carcinoma during a 7-year period points to the fact that the number of newly detected cases of advanced disease stages did not decrease significantly despite the affordable and simple methods of early detection. This result underlines the importance of implementation of a National screening programme in the general population for early detection of cervical neoplasms. The excellent results of National screening programmes in other European countries lend support to this approach.
宫颈癌是伏伊伏丁那州妇科癌症女性患者的主要死因。塞尔维亚目前在欧洲宫颈癌发病率方面位居首位,在死亡率方面位居第二。
数据取自伏伊伏丁那肿瘤研究所2001 - 2007年恶性肿瘤登记册。根据国际妇产科联盟(FIGO)宫颈癌分类,将患者按疾病分期分为3组。使用线性趋势分析和t检验对数据进行分析。
7年间I - IIA期患者组登记病例数的线性趋势显示该疾病患病率无显著变化。在诊断为IIB期的女性组中,未观察到上升或下降趋势的统计学差异。在晚期疾病阶段(III期和IV期)观察到的趋势显示患者数量略有下降,但无统计学意义。
7年间宫颈癌患者数量的线性趋势表明,尽管早期检测方法经济简便,但新检测出的晚期疾病阶段病例数并未显著减少。这一结果凸显了在普通人群中实施国家筛查计划以早期发现宫颈肿瘤的重要性。其他欧洲国家国家筛查计划的优异成果支持了这一做法。